Literature DB >> 26170450

Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation.

Qiuling Li1, Yuewei Li2, Bingnan Gu3, Lei Fang4, Pengbo Zhou2, Shilai Bao5, Lan Huang6, Xing Dai7.   

Abstract

Pygopus 2 (Pygo2/PYGO2) is an evolutionarily conserved coactivator and chromatin effector in the Wnt/β-catenin signaling pathway that regulates cell growth and differentiation in various normal and malignant tissues. Although PYGO2 is highly overexpressed in a number of human cancers, the molecular mechanism underlying its deregulation is largely unknown. Here we report that Pygo2 protein is degraded through the ubiquitin/proteasome pathway and is posttranslationally stabilized through phosphorylation by activated phosphatidylinositol 3-kinase/Akt signaling. Specifically, Pygo2 is stabilized upon inhibition of the proteasome, and its intracellular level is regulated by Cullin 4 (Cul4) and DNA damage-binding protein 1 (DDB1), components of the Cul4-DDB1 E3 ubiquitin ligase complex. Furthermore, Pygo2 is phosphorylated at multiple residues, and Akt-mediated phosphorylation at serine 48 leads to its decreased ubiquitylation and increased stability. Finally, we provide evidence that Akt and its upstream growth factors act in parallel with Wnt to stabilize Pygo2. Taken together, our findings highlight chromatin regulator Pygo2 as a common node downstream of oncogenic Wnt and Akt signaling pathways and underscore posttranslational modification, particularly phosphorylation and ubiquitylation, as a significant mode of regulation of Pygo2 protein expression.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Akt; Cul4; DDB1; E3 ubiquitin ligase; Pygo2; Wnt signaling; phosphorylation; ubiquitin ligase; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2015        PMID: 26170450      PMCID: PMC4571880          DOI: 10.1074/jbc.M115.639419

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  97 in total

1.  Akt participation in the Wnt signaling pathway through Dishevelled.

Authors:  S Fukumoto; C M Hsieh; K Maemura; M D Layne; S F Yet; K H Lee; T Matsui; A Rosenzweig; W G Taylor; J S Rubin; M A Perrella; M E Lee
Journal:  J Biol Chem       Date:  2001-03-09       Impact factor: 5.157

2.  Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.

Authors:  C Desbois-Mouthon; A Cadoret; M J Blivet-Van Eggelpoël; F Bertrand; G Cherqui; C Perret; J Capeau
Journal:  Oncogene       Date:  2001-01-11       Impact factor: 9.867

Review 3.  PI3K-PKB/Akt pathway.

Authors:  Brian A Hemmings; David F Restuccia
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

4.  Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.

Authors:  W J Ryves; A J Harwood
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

5.  Pygo2 regulates β-catenin-induced activation of hair follicle stem/progenitor cells and skin hyperplasia.

Authors:  Peng Sun; Kazuhide Watanabe; Magid Fallahi; Briana Lee; Megan E Afetian; Catherine Rheaume; Di Wu; Valerie Horsley; Xing Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

6.  Essential role of the CUL4B ubiquitin ligase in extra-embryonic tissue development during mouse embryogenesis.

Authors:  Liren Liu; Yan Yin; Yuewei Li; Lisa Prevedel; Elizabeth H Lacy; Liang Ma; Pengbo Zhou
Journal:  Cell Res       Date:  2012-03-27       Impact factor: 25.617

Review 7.  Building and remodelling Cullin-RING E3 ubiquitin ligases.

Authors:  John R Lydeard; Brenda A Schulman; J Wade Harper
Journal:  EMBO Rep       Date:  2013-11-15       Impact factor: 8.807

8.  WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation.

Authors:  Dong Wook Choi; Wooju Na; Mohammad Humayun Kabir; Eunbi Yi; Seonjeong Kwon; Jeonghun Yeom; Jang-Won Ahn; Hee-Hyun Choi; Youngha Lee; Kyoung Wan Seo; Min Kyoo Shin; Se-Ho Park; Hae Yong Yoo; Kyo-Ichi Isono; Haruhiko Koseki; Seong-Tae Kim; Cheolju Lee; Yunhee Kim Kwon; Cheol Yong Choi
Journal:  Mol Cell       Date:  2013-07-18       Impact factor: 17.970

9.  Polo-like kinase 4 autodestructs by generating its Slimb-binding phosphodegron.

Authors:  Joseph E Klebba; Daniel W Buster; Annie L Nguyen; Stephen Swatkoski; Marjan Gucek; Nasser M Rusan; Gregory C Rogers
Journal:  Curr Biol       Date:  2013-10-31       Impact factor: 10.834

10.  Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.

Authors:  K Watanabe; M Fallahi; X Dai
Journal:  Oncogene       Date:  2013-01-21       Impact factor: 9.867

View more
  4 in total

1.  AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.

Authors:  Ni Li; Wei Xue; Huairui Yuan; Baijun Dong; Yufeng Ding; Yongfeng Liu; Min Jiang; Shan Kan; Tongyu Sun; Jiale Ren; Qiang Pan; Xiang Li; Peiyuan Zhang; Guohong Hu; Yan Wang; Xiaoming Wang; Qintong Li; Jun Qin
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

2.  GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells.

Authors:  Qianqian Pang; Chunyi Liu; Yulong Qiao; Jian Zhao; Sin Man Lam; Mei Mei; Guanghou Shui; Shilai Bao; Qiuling Li
Journal:  Sci China Life Sci       Date:  2021-03-16       Impact factor: 6.038

Review 3.  Phosphorylation regulates cullin-based ubiquitination in tumorigenesis.

Authors:  Yifan Chen; Xuejing Shao; Ji Cao; Hong Zhu; Bo Yang; Qiaojun He; Meidan Ying
Journal:  Acta Pharm Sin B       Date:  2020-09-19       Impact factor: 11.413

4.  PRMT7 targets of Foxm1 controls alveolar myofibroblast proliferation and differentiation during alveologenesis.

Authors:  Huacheng He; Jilin Chen; Jian Zhao; Peizhun Zhang; Yulong Qiao; Huajing Wan; Jincheng Wang; Mei Mei; Shilai Bao; Qiuling Li
Journal:  Cell Death Dis       Date:  2021-09-08       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.